An OR-logic-gated polarity-switching biosensor for multiplexed dual-mode thalassemia screening
Biosensors and Bioelectronics · 2027-01 · 316 · 119322
DOI: 10.1016/j.bios.2026.119322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027-01. Verfasst von Yiwei Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Optic-electric Chemo/Biosensing and Molecular Recognition (Guangxi Minzu University), Education Department of Guangxi Zhuang Autono…. Hauptthemen laut MEDLINE: Biosensing Techniques, Thalassemia. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangxi Natural Science Foundation.
Abstract (Originalsprache)
The concurrent detection of multiple thalassemia mutations remains challenging due to the limitations of conventional single-readout biosensors in terms of reliability and sensitivity. Herein, we report an intelligent photoelectrochemical (PEC)/colorimetric dual-mode biosensor that integrates an OR logic gate with a DNAzyme Walker cascade amplification strategy, built on a proposed Z-scheme Bi2S3/Bi-BiOI heterojunction whose proposed Z-scheme charge-transfer pathway is supported by Mott-Schottky and photovoltage measurements. The OR logic gate enables parallel recognition of CD142 and CD41-42 mutations, outputting a unified trigger to initiate a nicking enzyme-assisted DNAzyme Walker. This autonomous machinery releases abundant G-quadruplex/hemin (G4-hemin) complexes, serving as a bifunctional signal transducer. Notably, the specific binding of G4-hemin to the electrode interface induces a distinct anodic-to-cathodic photocurrent polarity switching, which, coupled with its intrinsic peroxidase-mimicking activity, allows for self-validated dual-signal output. The platform achieves limits of detection down to 28.7 aM (PEC) and 2.6 fM (colorimetric) across a wide linear range (0.1 fM-0.1 μM). Furthermore, the dual-mode design effectively eliminates false positives through signal cross-validation. Practical application in human serum yielded satisfactory recoveries (94.1-107.8%), highlighting the platform's potential for high-precision genetic screening in resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Optic-electric Chemo/Biosensing and Molecular Recognition (Guangxi Minzu University), Education Department of Guangxi Zhuang Autonomous Region; Guangxi Key Laboratory of Chemistry and Engineering of Fo…
- The Reproductive Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, China. Electronic address: 406561460@qq.com.
Förderung
- National Natural Science Foundation of China
- Guangxi Natural Science Foundation
Zitieren
APA
Zheng, Y., Feng, N., Xiao, W., Wei, R., Lu, W., Li, X., Tan, X., Wei, Y., Huang, K., & Wu, J. (2027). An OR-logic-gated polarity-switching biosensor for multiplexed dual-mode thalassemia screening. Biosensors and Bioelectronics, 316, 119322. https://doi.org/10.1016/j.bios.2026.119322
Vancouver
Zheng Y, Feng N, Xiao W, Wei R, Lu W, Li X, et al. An OR-logic-gated polarity-switching biosensor for multiplexed dual-mode thalassemia screening. Biosensors and Bioelectronics. 2027;316:119322. doi:10.1016/j.bios.2026.119322
BibTeX
@article{Zheng2027,
author = {Zheng, Yiwei and Feng, Na and Xiao, Wenwen and Wei, Ruxia and Lu, Wenjie and Li, Xu and Tan, Xuecai and Wei, Yashu and Huang, Kejing and Wu, Jiawen},
title = {An OR-logic-gated polarity-switching biosensor for multiplexed dual-mode thalassemia screening},
journal = {Biosensors and Bioelectronics},
year = {2027},
volume = {316},
pages = {119322},
doi = {10.1016/j.bios.2026.119322}
}
EUVIMED